|
This new report synthesizes the emerging science behind vaccines, and how biotechnology and pharmaceutical companies are using that science against our deadliest foes: pandemics, cancer and HIV.
The market for vaccines is expanding fast as scientists and drug developers move quickly to turn promise into cures. Vaccines used to be to prevent illness, but now vaccines are being developed to treat people already ill. This report updates the key recent scientific developments relating vaccines, and discusses the problems and successes drug developers have had in the field.
BioWorld Today's Advancing Vaccines: New Science, New Opportunities discusses the major uses for vaccines – seasonal flu, pandemic flu, HIV and cancer – providing both the science behind them and the efforts of companies to develop that science into marketable products. An example of topics discussed include:
- Cancer vaccines
- HIV vaccines
- Seasonal and pandemic flus
- Sciences behind vaccines
- And much more!
This innovative, concise report includes recent scientific advancements that will drive the vaccines market in the future, and current efforts by companies to move their products toward the marketplace. The BioWorld Today's Advancing Vaccines: New Science, New Opportunities covers vaccine use in both the therapeutic and prophylactic fields, specifically covering seasonal and Swine flus, cancer vaccines, and HIV vaccines.
People who need this report:
- Pharma R&D specialists
- Regulatory Professionals
- Biotech senior management
- Attorneys serving biotech firms
- Research scientists
- Health professionals
- Biologists
- Risk managers
- Immunologists
- Vaccine manufacturers
- Infection control professionals
This report can be purchased in print or PDF.
To view the table of contents, click here.
|
Print and PDF Version:
|
|
Price: $199 + ($17.95 s&h)
|
Order Now
|
|
